Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Versus Intravenous Tranexamic Acid for Blood Loss Prevention in Off-Pump Coronary Artery Bypass Surgery
NCT07740330Phase 4Not yet recruiting
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in perioperative bleeding (2 arms), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Cumulative Chest Tube Blood Loss Within 24 Hours After Surgery. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on NCT07740330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07740330.